GLP-1 weight-loss drugs are in the news because so many people are using them to treat obesity and diabetes. With so many ...
New research reveals these medications impact everything from heart health to restaurant menus.
With weight loss drugs taking the world by storm, more people are exploring adding these medical marvels to their toolkits. Aside from the impressive results, GLP-1s seem to be increasingly easy for ...
In this interview, News Medical speaks with Dr Bryony Henderson, Medical Director for the UK and US at MedExpress, about the evolving role of GLP‑1 agonists in obesity care and the future of metabolic ...
If you live with obesity or type 2 diabetes, your doctor may have talked to you about GIP/GLP-1 agonist medications, such as tirzepatide (Mounjaro or Zepbound), which may help you lose weight. And ...
Everyday Health on MSN
How to talk to your doctor about GLP-1 weight loss drugs
Come prepared with the right questions and information about your goals, weight loss history, and diet and exercise plan to get the most out of a GLP-1 conversation.
Risks for kidney failure and major cardiovascular events between three GLP-1 receptor agonists were similar among veterans with diabetes. Mortality risk and certain adverse events differed between the ...
Weight-loss drugs like semaglutide may melt fat, but at the cost of muscle mass. A new review reveals how to protect your strength while reaping the benefits. Study: Glucagon-like peptide-1 receptor ...
Pharmaceutical vending machine at an airport. Image by Tim Sandle. Pharmaceutical vending machine at an airport. Image by Tim Sandle. Can a new discovery usher in a new generation of GLP-1 peptides – ...
GLP-1RAs improved RA disease activity, pain scores, weight, cholesterol, and HbA1c levels in patients with a BMI ≥27. Nearly one-third of patients discontinued GLP-1RA therapy due to gastrointestinal ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results